Leukoencephalopathy with calcifications and cysts
ICD-10 G93.43 is a billable code used to indicate a diagnosis of leukoencephalopathy with calcifications and cysts.
Leukoencephalopathy with calcifications and cysts is a rare neurological disorder characterized by the presence of white matter abnormalities in the brain, often accompanied by calcifications and cystic lesions. This condition can lead to a variety of neurological symptoms, including cognitive decline, motor dysfunction, and seizures. Patients may experience pain syndromes due to nerve involvement, and autonomic disorders may manifest as dysregulation of bodily functions such as heart rate and blood pressure. Hydrocephalus, or the accumulation of cerebrospinal fluid in the brain, can also occur, leading to increased intracranial pressure and further neurological complications. The etiology of this condition can be genetic or acquired, and it is essential for clinicians to conduct thorough evaluations, including neuroimaging and genetic testing, to establish a diagnosis. Management typically involves symptomatic treatment and supportive care, as there is currently no cure for the underlying condition.
Detailed neurological examination findings, imaging results, and treatment plans.
Patients presenting with cognitive decline, seizures, or motor dysfunction.
Ensure that all neurological assessments are documented clearly to support the diagnosis.
Comprehensive imaging reports detailing the presence of calcifications and cysts.
Imaging studies ordered for patients with suspected leukoencephalopathy.
Radiologists should provide clear descriptions of findings to assist in accurate coding.
Used to evaluate for leukoencephalopathy in patients presenting with neurological symptoms.
Document the clinical indications for the CT scan and findings.
Radiologists should ensure clarity in reporting findings related to leukoencephalopathy.
Common symptoms include cognitive decline, seizures, motor dysfunction, headaches, and autonomic dysregulation.
Diagnosis typically involves a combination of clinical evaluation, neuroimaging studies, and sometimes genetic testing to identify underlying causes.
